945 related articles for article (PubMed ID: 25643805)
1. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV.
Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR
J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
[TBL] [Abstract][Full Text] [Related]
3. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS
Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305
[TBL] [Abstract][Full Text] [Related]
6. A novel genotype VII Newcastle disease virus vaccine candidate generated by mutation in the L and F genes confers improved protection in chickens.
Ji Y; Liu T; Du Y; Cui X; Yu Q; Wang Z; Zhang J; Li Y; Zhu Q
Vet Microbiol; 2018 Mar; 216():99-106. PubMed ID: 29519533
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
[TBL] [Abstract][Full Text] [Related]
8. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
[TBL] [Abstract][Full Text] [Related]
9. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
[TBL] [Abstract][Full Text] [Related]
10. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
11. Recombinant infectious bronchitis virus (IBV) H120 vaccine strain expressing the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) protects chickens against IBV and NDV challenge.
Yang X; Zhou Y; Li J; Fu L; Ji G; Zeng F; Zhou L; Gao W; Wang H
Arch Virol; 2016 May; 161(5):1209-16. PubMed ID: 26873815
[TBL] [Abstract][Full Text] [Related]
12. Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs.
Hu Z; Hu S; Meng C; Wang X; Zhu J; Liu X
Avian Dis; 2011 Sep; 55(3):391-7. PubMed ID: 22017036
[TBL] [Abstract][Full Text] [Related]
13. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
Manoharan VK; Varghese BP; Paldurai A; Samal SK
PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
[TBL] [Abstract][Full Text] [Related]
14. Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
Xiao S; Nayak B; Samuel A; Paldurai A; Kanabagattebasavarajappa M; Prajitno TY; Bharoto EE; Collins PL; Samal SK
PLoS One; 2012; 7(12):e52751. PubMed ID: 23285174
[TBL] [Abstract][Full Text] [Related]
15. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
[TBL] [Abstract][Full Text] [Related]
16. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
[TBL] [Abstract][Full Text] [Related]
17. The protection conferred against virulent Newcastle disease virus (vNDV) genotype VII by commercial double recombinant HVT vaccines and NDV live-attenuated vaccine as prime/boost vaccination regimens in commercial broiler chickens carrying maternally-derived antibodies (MDAs) against NDV.
Ghanem IAE; Abdullatif TM; Hassanin O
Avian Pathol; 2023 Aug; 52(4):251-263. PubMed ID: 37158499
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization, pathogenicity, and protection efficacy analysis of 2 wild-type lentogenic class I Newcastle disease viruses from chickens in China.
Wu C; Hu J; Ci X; Nie Y; Chen D; Zhang X; Chen W; Lin W; Xie Q
Poult Sci; 2019 Feb; 98(2):602-612. PubMed ID: 30376072
[TBL] [Abstract][Full Text] [Related]
19. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
[TBL] [Abstract][Full Text] [Related]
20. Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design.
Izquierdo-Lara R; Chumbe A; Calderón K; Fernández-Díaz M; Vakharia VN
PLoS One; 2019; 14(11):e0209539. PubMed ID: 31725727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
